Patient-derived tumour xenografts as models for oncology drug development

被引：0
|
作者：
John J. Tentler
Aik Choon Tan
Colin D. Weekes
Antonio Jimeno
Stephen Leong
Todd M. Pitts
John J. Arcaroli
Wells A. Messersmith
S. Gail Eckhardt
机构：
[1] School of Medicine,Division of Medical Oncology, Department of Medicine
[2] University of Colorado,undefined
来源：
Nature Reviews Clinical Oncology | 2012年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this Review, Tentler et al. present the opportunities and challenges of using patient-derived tumour xenograft models in oncology drug development, provide specific disease examples, and describe concepts regarding predictive biomarker development and future applications.
引用
收藏
页码：338 / 350
页数：12
相关论文
共 50 条
  • [21] Patient-Derived Xenografts as Tools in Pharmaceutical Development
    Izumchenko, E.
    Meir, J.
    Bedi, A.
    Wysocki, P. T.
    Hoque, M. O.
    Sidransky, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (06) : 612 - 621
  • [22] Comparative mutational landscape analysis of patient-derived tumour xenografts
    Mariana Brait
    Evgeny Izumchenko
    Luciane T Kagohara
    Samuel Long
    Piotr T Wysocki
    Brian Faherty
    Elana J Fertig
    Tin Oo Khor
    Elizabeth Bruckheimer
    Gilson Baia
    Daniel Ciznadija
    Ido Sloma
    Ido Ben-Zvi
    Keren Paz
    David Sidransky
    British Journal of Cancer, 2017, 116 : 515 - 523
  • [23] Patient-derived xenografts in surgical oncology: A short research review
    Hernandez, Matthew C.
    Leiting, Jennifer L.
    Joshi, Vidhu B.
    Yang, Lin
    Leong, Hon
    Thomas, Ryan M.
    Fleming, Jason
    Truty, Mark J.
    SURGERY, 2020, 168 (06) : 1021 - 1025
  • [24] Preclinal models of patient-derived xenografts on humanized mice for translational immuno-oncology research
    Stecklum, M.
    Wulf-Goldenberg, A.
    Paterka, M.
    Brzezicha, B.
    Fichtner, I.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E101 - E101
  • [25] Patient-derived xenografts effectively capture patient clinical responses to oncology therapy
    Davies, A.
    Stebbing, J.
    Zacharoulis, S.
    Gaya, A.
    McGuire, W.
    Harris, W.
    Maki, R.
    Hidalgo, M.
    Vasquez-Dunddel, D.
    Ciznadija, D.
    Katz, A.
    Sidransky, D.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S203 - S203
  • [26] Tumour stromal morphology impacts nanomedicine cytotoxicity in patient-derived xenografts
    San Martin, Juan A. Delgado
    Hare, Jennifer I.
    Yates, James W. T.
    Barry, Simon T.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (05) : 1247 - 1252
  • [27] Patient-derived murine xenografts
    Annette Fenner
    Nature Reviews Urology, 2015, 12 (10) : 536 - 536
  • [28] Patient-derived bladder cancer xenografts as a platform for drug development in bladder cancer.
    Pan, Amy Wang
    Zhang, Hongyong
    Lin, Tzu-Yin
    Li, Yuanpei
    Li, Tianhong
    Keck, James
    Tepper, Clifford
    Airhart, Susan D.
    Liu, Edison T.
    Pan, Chong-xian
    White, Ralph de Vere
    Lam, Kit S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
    Lin, Dong
    Wyatt, Alexander W.
    Xue, Hui
    Wang, Yuwei
    Dong, Xin
    Haegert, Anne
    Wu, Rebecca
    Brahmbhatt, Sonal
    Mo, Fan
    Jong, Lina
    Bell, Robert H.
    Anderson, Shawn
    Hurtado-Coll, Antonio
    Fazli, Ladan
    Sharma, Manju
    Beltran, Himisha
    Rubin, Mark
    Cox, Michael
    Gout, Peter W.
    Morris, James
    Goldenberg, Larry
    Volik, Stanislav V.
    Gleave, Martin E.
    Collins, Colin C.
    Wang, Yuzhuo
    CANCER RESEARCH, 2014, 74 (04) : 1272 - 1283
  • [30] Preclinical models for translational immuno-oncology research: patient-derived xenografts on humanized mice.
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Klinghammer, Konrad
    Joehrens, Korinna
    Walther, Wolfgang
    Hoffmann, Jens
    CANCER RESEARCH, 2021, 81 (13)
12345